Resistance to Imatinib Mesylate-induced apoptosis in acute lymphoblastic leukemia is associated with PTEN down-regulation due to promoter hypermethylation
Authors:
- 1 May 2008
- journal article
- Published by Elsevier in Leukemia Research
- Vol. 32 (5) , 709-716
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Resistance of Philadelphia-chromosome positive leukemia towards the kinase inhibitor imatinib (STI571, Glivec): a targeted oncoprotein strikes backLeukemia, 2003
- Perspectives on the development of a molecularly targeted agentCancer Cell, 2002
- Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or AmplificationScience, 2001
- Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia ChromosomeNew England Journal of Medicine, 2001
- CGP57148B (STI-571) induces differentiation and apoptosis and sensitizes Bcr-Abl–positive human leukemia cells to apoptosis due to antileukemic drugsBlood, 2000
- BIOLOGY OF CHRONIC MYELOGENOUS LEUKEMIAHematology/Oncology Clinics of North America, 1998
- Pathophysiology of CML: Do defects in integrin function contribute to the premature circulation and massive expansion of the BCR/ABL positive clone?Journal of Laboratory and Clinical Medicine, 1997
- Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemiaBlood, 1994
- Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia. Decreased adhesion to stroma and fibronectin but increased adhesion to the basement membrane components laminin and collagen type IV.Journal of Clinical Investigation, 1992
- Induction of Chronic Myelogenous Leukemia in Mice by the P210
bcr/abl
Gene of the Philadelphia ChromosomeScience, 1990